Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder

Background: Duloxetine hydrochloride (DUL) is an antidepressant included in the pharmacological class of serotonin–norepinephrine reuptake inhibitors approved for the treatment of major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Psychiatry
Auteurs principaux: Muscatello, Maria Rosaria Anna, Zoccali, Rocco A., Pandolfo, Gianluca, Mangano, Paolo, Lorusso, Simona, Cedro, Clemente, Battaglia, Fortunato, Spina, Edoardo, Bruno, Antonio
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019
Sujets:
Psychiatry
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6844294/
https://ncbi.nlm.nih.gov/pubmed/31749717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2019.00772
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires